A Ludwig Cancer Research study has identified a metabolic switch in the immune system’s T cells that is essential to the generation of memory T cells–which confer lasting immunity to previously encountered pathogens–and a T cell subtype found in tumors that drives anti-tumor responses during immunotherapy.